American Journal of Kidney Diseases
Volume 49, Issue 6 , Pages 814-823 , June 2007

Intravenous Paricalcitol for Treatment of Secondary Hyperparathyroidism in Children on Hemodialysis

  • Larry A. Greenbaum, MD, PhD

      Affiliations

    • Emory University and Children’s Healthcare of Atlanta, GA
    • Corresponding Author InformationAddress correspondence to Larry Greenbaum, MD, PhD, Emory University and Children’s Healthcare of Atlanta, GA 30322.
    • ,
  • Nadine Benador, MD

      Affiliations

    • University of California at San Diego, La Jolla
    • ,
  • Stuart L. Goldstein, MD

      Affiliations

    • Baylor College of Medicine/Texas Children’s Hospital, Houston, TX
    • ,
  • Ana Paredes, MD

      Affiliations

    • Miami Children’s Hospital, Miami, FL
    • ,
  • Joel Z. Melnick, MD

      Affiliations

    • Abbott Laboratories, Abbott Park, IL
    • ,
  • Susan Mattingly, BSN

      Affiliations

    • Abbott Laboratories, Abbott Park, IL
    • ,
  • Michael Amdahl, MS

      Affiliations

    • Abbott Laboratories, Abbott Park, IL
    • ,
  • Laura A. Williams, MD, MPH

      Affiliations

    • Abbott Laboratories, Abbott Park, IL
    • ,
  • Isidro B. Salusky, MD

      Affiliations

    • David Geffen School of Medicine at UCLA, Los Angeles, CA.

Received 31 October 2006 ,Accepted 13 March 2007.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 Originally published online as doi:10.1053/j.ajkd.2007.03.008 on May 4, 2007.

 Support: This study was funded by Abbott Laboratories. Potential conflicts of interest: Dr Williams, Dr Melnick, and Mr. Amdahl are employees of Abbott Laboratories, the manufacturer of paricalcitol.

PII: S0272-6386(07)00640-3

doi: 10.1053/j.ajkd.2007.03.008

American Journal of Kidney Diseases
Volume 49, Issue 6 , Pages 814-823 , June 2007

Article Tools

* Image Usage & Resolution